Neujahrsbonus 2026: Dein Geschenk zum neuen Jahr

Eröffne Dein Depot bei unserem Broker finanzen.net ZERO und sicher Dir mit dem Code 'WINTER2025' 1 Gratis-Aktie, 1 ETF-Anteil und bis zu 300 € Wechselprämie!
Es gelten die Aktionsfristen und Teilnahmebedingungen.

Nicht mehr anzeigen

Charles River Laboratories International Aktie

Kaufen

Verkaufen

Aktien-Sparplan anlegen Aktien-Sparplan anlegen

171,95 EUR -0,65 EUR -0,38 %

30.12.2025

BMN

199,58 USD -2,50 USD -1,24 %

31.12.2025

BTT

Charles River Laboratories International jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)

Jetzt loslegen

Direkt handeln

Bei einem anderen Broker handeln

Marktkap.8,46 Mrd. EUR

KGV919,86Div. Rendite0,00%

WKN939391

ISINUS1598641074

SymbolCRL

Charles River Laboratories International Aktien News

Sortieren:Datum Meistgelesen

05.06.23BusinesswireCharles River Laboratories to Present at William Blair and Jefferies Conferences

31.05.23PR NewswireWheeler Bio and Charles River Laboratories Announce Agreement to Build and Operate RightSource(SM) Laboratory

31.05.23BusinesswireCharles River Laboratories and Wheeler Bio Announce Agreement to Build and Operate RightSourceSM Laboratory

31.05.23PR NewswireCRL ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of July 18, 2023 in the Class Action Filed on Behalf of Charles River Laboratories International, Inc. Shareholders

25.05.23PR NewswireCRL LAWSUIT ALERT: Levi & Korsinsky Notifies Charles River Laboratories International, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

24.05.23PR NewswireInvestor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Charles River Laboratories International, Inc. (CRL) Investors of Class Action and to Actively Participate

11.05.23BusinesswireCharles River Laboratories Announces First-Quarter 2023 Results

01.05.23BusinesswireCharles River Laboratories Launches Next Generation Sequencing Services for Bacterial Identification and Fungal ID

11.04.23BusinesswireCharles River Laboratories Schedules First-Quarter 2023 Earnings Release and Conference Call

10.04.23BusinesswireCharles River Laboratories Showcases End-to-End Oncology Capabilities at AACR 2023

31.03.23PR NewswireCRL LOSS ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Charles River Laboratories International, Inc. Investors to Inquire About Securities Class Action Investigation - CRL

13.03.23PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Charles River Laboratories International, Inc. - CRL

13.03.23BusinesswireCharles River Launches Apollo™, an Industry-Leading, Secure, Cloud-Based Platform for Real-Time Toxicology Study Data

09.03.23BusinesswireCharles River Launches Helper Plasmid to Streamline Adeno-Associated Viral Vector Manufacturing

24.02.23PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Charles River Laboratories International, Inc. - CRL

16.02.23BusinesswireCharles River and Flagship’s Pioneering Medicines Enter Agreement Leveraging AI-Powered Logica with Aim of Creating Novel Therapies for Unmet Medical Needs

15.02.23BusinesswireCharles River and Purespring Therapeutics Announce Gene Therapy Manufacturing Collaboration

13.02.23BusinesswireCharles River Launches Novel IgY-based ELISA Kit for the Detection and Quantitation of Residual Host Cell Protein

09.02.23BusinesswireCharles River Laboratories Schedules Fourth-Quarter 2022 Earnings and 2023 Guidance Release and Conference Call

30.01.23BusinesswireCharles River Laboratories Acquires SAMDI Tech

18.01.23BusinesswireCharles River and Rznomics Announce RNA-based Anticancer Gene Therapy Manufacturing Alliance

16.01.23BusinesswireCharles River Launches CliniPrime Suite of GMP-Compliant Cellular Products

12.01.23BusinesswireCharles River Establishes eXpDNA™ Plasmid Manufacturing Platform to Expedite DNA Programs

09.01.23BusinesswireCharles River Laboratories to Present at J.P. Morgan Healthcare Conference

Charles River Laboratories International News

Charles River Laboratories International News: auf dieser Seite finden Sie alle Charles River Laboratories International News und Nachrichten zur Charles River Laboratories International Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Charles River Laboratories International News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Charles River Laboratories International News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.